SL Science Holding Ltd (SLBT)

• Market cap: $1.59B
• 1 day: 5.99%
• 5 days: -7.52%
• 1 month: -40.17%
• 3 months: -15.02%
• 6 months: -15.02%
• Year to date: -15.02%
• 1 year: -15.02%
• 5 years: -15.02%
• 10 years: -15.02%
• Sector: Healthcare
• Industry: Biotechnology

About: SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

Employees: 20